We are participating in the upcoming Keystone Symposium in Banff (23rd-26th February) focusing on “MASH Pathogenesis and Therapeutic Approaches”, held in conjunction with the “Obesity and Adipose Tissue” meeting. This prestigious event will bring together leading experts to discuss the latest advancements in understanding and treating metabolic liver diseases. Stay tuned for insights and key takeaways from our team as we contribute to shaping the future of MASH therapy.
